Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

GLI and EGF signalling affect Basal Cell Carcinoma development and could be therapeutic targets.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Understanding EGFR roles could lead to new hair loss treatments.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

High DKK1 levels predict worse survival in head and neck cancer.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

mTOR may link different pathways in hair follicle tumor formation.

Certain cancer drugs can cause skin issues like rashes and itching.

Collagen XVIII and Bmx tyrosine kinase are important for hair growth and skin cancer development.

EGFR helps mouse hair follicles stop growing by reducing certain growth regulators.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

EZH1 and EZH2 are crucial for healthy hair growth and skin repair.

Edar signaling is crucial for proper hair follicle development and function.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

Radiation therapy in breast cancer patients changes gene expression related to DNA damage, fibroblast growth, and hair follicle development, which could help improve treatment for radiation-induced fibrosis.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

The enzyme PA-PLA1α is important for proper hair follicle development.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Middle Eastern patients with epidermolysis bullosa show specific genetic mutations linked to different types of the disease.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Abnormal activation of hair follicle stem cells and Wnt/β-catenin signaling contributes to sebaceous neoplasms.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.

Edar signaling is crucial for controlling hair growth and regression.

CK7 and CK20 help identify and classify tumors for accurate cancer diagnosis.

Basal cell epithelioma likely starts from the hair follicle's outer root sheath.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.